Raaj Medisafe India Limited has formally disclosed its acquisition of Fabrizo Industries Private Limited under SEBI Listing Regulations. The company filed the disclosure on December 23, 2025, providing comprehensive details about the strategic acquisition that forms part of its ₹43.00 crore expansion plan.

Acquisition Details and Strategic Rationale

The acquisition involves purchasing the plant, machinery, and related business operations of Fabrizo Industries Private Limited, located at Plot Nos. 46-50, Mapusa Industrial Estate, near St. Xaviers College, Bardez, Mapusa, Goa. The total consideration for the acquisition amounts to ₹28.00 crores in cash.

The proposed acquisition is expected to strengthen the company's product portfolio and broaden its customer base, thereby enhancing its position in the alco-bev packaging industry.

Target Company Background and Performance

Fabrizo Industries, incorporated on July 3, 2009, is engaged in manufacturing alco-bev closures with principal business customers in the alcoholic beverage industry. The company has demonstrated consistent revenue performance over recent years.

Complete Expansion Framework

The Fabrizo acquisition represents a significant component of Raaj Medisafe's broader expansion strategy. The board had previously approved a comprehensive investment plan totaling ₹43.00 crores.

Fundraising and Corporate Actions

To support the expansion initiatives, the board approved raising funds up to ₹18.01 crores through preferential allotment to select non-promoter investors. The company has also scheduled an extraordinary general meeting to address critical business items including authorized capital increase from ₹15.00 crores to ₹18.00 crores.

The acquisition does not involve any related party transactions, and no governmental or regulatory approvals are required for completion. The transaction is expected to be completed subject to fulfillment of closing conditions, positioning Raaj Medisafe for enhanced growth in the packaging materials and alco-bev closures segments.

Raaj Medisafe India Limited has reported a significant improvement in its financial performance for the quarter ended September 30, 2025. The company's board meeting, held on November 12, 2025, approved the unaudited financial results and several key business decisions.

Financial Highlights

The company's financial performance for Q2 FY2026 showed substantial growth compared to the same period last year:

For the half-year period ended September 30, 2025:

• Total revenue reached Rs 3,423.10 lakhs, up from Rs 2,343.00 lakhs in the previous year.
• Net profit increased to Rs 318.72 lakhs from Rs 162.58 lakhs, marking a 96% growth.

Key Business Decisions

The Board of Directors made several important decisions during the meeting:

1. Term Loan Approval: The company has approved availing a term loan of Rs 12.00 crores from Bank of Baroda, Indore.

2. Bank Account Shifting: Approval was given to shift the company's current and cash credit accounts from HDFC Bank, Teen Batti Branch Ujjain to HDFC Bank, Maksi Road, Ujjain.

3. Share Forfeiture: The Board approved the forfeiture of 63,300 equity shares due to non-payment of calls in arrears.

Other Notable Points

• The company's financial results were reviewed by the audit committee and approved by the Board of Directors.
• GDK & Associates, Chartered Accountants, conducted a review of the financial statements and found no material misstatements.
• The board meeting, which commenced at 3:00 PM, concluded at 5:00 PM.

Raaj Medisafe India Limited, with its registered office in Ujjain, Madhya Pradesh, continues to show strong growth in its operations. The significant increase in revenue and profitability indicates the company's focus on expansion and operational efficiency.

Investors and stakeholders may view these results positively, especially considering the substantial improvement in earnings per share. The approval of a new term loan suggests that the company may be preparing for future growth opportunities.